{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:38:05Z","timestamp":1784932685583,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.euf.2020.06.002","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T22:53:23Z","timestamp":1591656803000},"page":"1086-1096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer"],"prefix":"10.1016","volume":"6","author":[{"given":"Meredith","family":"Mihalopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4602-3991","authenticated-orcid":false,"given":"Navneet","family":"Dogra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nihal","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Badani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Kyprianou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2020.06.002_bib0005","doi-asserted-by":"crossref","unstructured":"Sun P, Lu X, Xu C, Sun W, Pan B. Understanding of COVID-19 based on current evidence. J Med Virol. In press. https:\/\/doi.org\/10.1002\/jmv.25722.","DOI":"10.1002\/jmv.25722"},{"key":"10.1016\/j.euf.2020.06.002_bib0010","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.euf.2020.06.002_bib0015","series-title":"Coronavirus disease 2019 (COVID-19) situation report\u201478","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.euf.2020.06.002_bib0020","first-page":"1","article-title":"Should COVID-19 concern nephrologists? Why and to what extent? The emerging impasse of angiotensin blockade","volume":"24126","author":"Perico","year":"2020","journal-title":"Nephron"},{"key":"10.1016\/j.euf.2020.06.002_bib0025","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2020.06.002_bib0030","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2020.06.002_bib0035","first-page":"1769","article-title":"COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?","volume":"323","author":"Patel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2020.06.002_bib0040","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.euf.2020.06.002_bib0045","doi-asserted-by":"crossref","unstructured":"Diao B, Feng Z, Wang C, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. medRxiv. In press. https:\/\/doi.org\/10.1101\/2020.03.04.20031120.","DOI":"10.1101\/2020.03.04.20031120"},{"key":"10.1016\/j.euf.2020.06.002_bib0050","doi-asserted-by":"crossref","unstructured":"Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Is there an association between COVID-19 mortality and the renin-angiotensin system\u2014a call for epidemiologic investigations. Clin Infect Dis. In press. https:\/\/doi.org\/10.1093\/cid\/ciaa329.","DOI":"10.1093\/cid\/ciaa329"},{"key":"10.1016\/j.euf.2020.06.002_bib0055","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.euf.2020.06.002_bib0060","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Kr\u00fcger N, M\u00fcller M, Drosten C, P\u00f6hlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. In press. https:\/\/doi.org\/10.1101\/2020.01.31.929042.","DOI":"10.1101\/2020.01.31.929042"},{"key":"10.1016\/j.euf.2020.06.002_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.euf.2020.06.002_bib0070","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1\u20137 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.euf.2020.06.002_bib0075","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.2174\/0929867324666170414162841","article-title":"Circulating ACE2 in cardiovascular and kidney diseases","volume":"24","author":"Anguiano","year":"2017","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.euf.2020.06.002_bib0080","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.metabol.2019.03.006","article-title":"Angiotensin-(1-7), adipokines and inflammation","volume":"95","author":"de Farias Lelis","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.euf.2020.06.002_bib0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.bcp.2018.08.045","article-title":"Angiotensin-(1-9) reduces cardiovascular and renal inflammation in experimental renin-independent hypertension","volume":"156","author":"Gonzalez","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.euf.2020.06.002_bib0090","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"10.1016\/j.euf.2020.06.002_bib0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.euf.2020.06.002_bib0100","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.euf.2020.06.002_bib0105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000375362","article-title":"Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats","volume":"131","author":"Qiao","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.euf.2020.06.002_bib0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.euf.2020.06.002_bib0115","doi-asserted-by":"crossref","unstructured":"Xu D, Zhang H, Zhou W, Wang LH, Cui XG. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak : a study based on single-cell transcriptome analysis. Intensive Care Med. In press. https:\/\/doi.org\/10.1007\/s00134-020-06026-1.","DOI":"10.1007\/s00134-020-06026-1"},{"key":"10.1016\/j.euf.2020.06.002_bib0120","unstructured":"https:\/\/doi.org\/10.1101\/2020.02.08.20021212Li Z, Wu M, Guo J, et al. Caution on kidney dysfunctions of 2019-nCoV patients. MedRxiv. In press. ."},{"key":"10.1016\/j.euf.2020.06.002_bib0125","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2020.06.002_bib0130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.15585\/mmwr.mm6913e2","article-title":"Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019\u2014United States, February 12\u2013March 28, 2020","volume":"69","author":"CDC COVID-19 Response Team","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.euf.2020.06.002_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.6004\/jnccn.2020.7560","article-title":"Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal","volume":"18","author":"Ueda","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.euf.2020.06.002_bib0140","series-title":"The role of telehealth in an evolving health care environment, workshop summary","author":"Board on Health Care Services Institute of Medicine","year":"2012"},{"key":"10.1016\/j.euf.2020.06.002_bib0145","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jamaoncol.2019.0393","article-title":"Treatment-related adverse events of PD-1 and PD-L1 inhibitors in clinical trials: a systematic review and meta-analysis","volume":"5","author":"Wang","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euf.2020.06.002_bib0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12098-020-03263-6","article-title":"A review of coronavirus disease-2019 (COVID-19)","volume":"87","author":"Singhal","year":"2020","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.euf.2020.06.002_bib0155","article-title":"U.S. coronavirus patients with other conditions hospitalized at higher rates","author":"Abbott","year":"2020","journal-title":"The Wall Street Journal"},{"key":"10.1016\/j.euf.2020.06.002_bib0160","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"COVID-19 in critically ill patients in the Seattle region\u2014case series","volume":"382","author":"Bhatraju","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2020.06.002_bib0165","doi-asserted-by":"crossref","unstructured":"Wang L, Li X, Chen H, et al. SARS-CoV-2 infection does not significantly cause acute renal injury: an analysis of 116 hospitalized patients with COVID-19 in a single hospital, Wuhan, China. SSRN Electron J. In press. https:\/\/doi.org\/10.2139\/ssrn.3541116.","DOI":"10.2139\/ssrn.3541116"},{"key":"10.1016\/j.euf.2020.06.002_bib0170","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.kint.2020.03.001","article-title":"The novel coronavirus 2019 epidemic and kidneys","volume":"97","author":"Naicker","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.euf.2020.06.002_bib0175","doi-asserted-by":"crossref","first-page":"m1174","DOI":"10.1136\/bmj.m1174","article-title":"Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?","volume":"368","author":"Extance","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.euf.2020.06.002_bib0180","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2215\/CJN.03340320","article-title":"Mitigating Risk of COVID-19 in Dialysis Facilities","volume":"15","author":"Kliger","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.euf.2020.06.002_bib0185","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ndt\/gfaa069","article-title":"Recommendations for the prevention, mitigation and containment of the emerging SARS-CoV-2 (COVID-19) pandemic in haemodialysis centres","volume":"35","author":"Basile","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.euf.2020.06.002_bib0190","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1523-1755.2005.67130.x","article-title":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome","volume":"67","author":"Chu","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.euf.2020.06.002_bib0195","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneph.2013.44","article-title":"Immune cell dysfunction and inflammation in end-stage renal disease","volume":"9","author":"Betjes","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.euf.2020.06.002_bib0200","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jcrc.2011.02.012","article-title":"Acute kidney injury in critically ill patients with pandemic influenza A pneumonia 2009 in Korea: a multicenter study","volume":"26","author":"Jung","year":"2011","journal-title":"J Crit Care"},{"key":"10.1016\/j.euf.2020.06.002_bib0205","doi-asserted-by":"crossref","unstructured":"Cao M, Zhang D, Wang Y, et al. Clinical features of patients infected with the 2019 novel coronavirus (COVID-19) in Shanghai, China. medRxiv. In press. https:\/\/doi.org\/10.1101\/2020.03.04.20030395.","DOI":"10.1101\/2020.03.04.20030395"},{"key":"10.1016\/j.euf.2020.06.002_bib0210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2020.06.002_bib0215","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1053\/j.ajkd.2011.05.032","article-title":"Podocyte disorders: core curriculum 2011","volume":"58","author":"Jefferson","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.euf.2020.06.002_bib0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-\u03b3-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.euf.2020.06.002_bib0225","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.06.002_bib0230","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"Liang","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euf.2020.06.002_bib0235","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.molmed.2004.07.008","article-title":"The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis","volume":"10","author":"Barry","year":"2004","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.euf.2020.06.002_bib0240","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s10637-011-9677-6","article-title":"Antiangiogenic treatments and mechanisms of action in renal cell carcinoma","volume":"30","author":"N\u00e9grier","year":"2012","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.euf.2020.06.002_bib0245","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2217\/fon-2017-0215","article-title":"PDL-1\/PD1 inhibitors: antibody or antinobody?","volume":"13","author":"Aoun","year":"2017","journal-title":"Future Oncol"},{"key":"10.1016\/j.euf.2020.06.002_bib0250","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000319","article-title":"Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma","volume":"8","author":"Labriola","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.euf.2020.06.002_bib0255","doi-asserted-by":"crossref","first-page":"v58","DOI":"10.1093\/annonc\/mdw328","article-title":"Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Escudier","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euf.2020.06.002_bib0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.eururo.2019.05.022","article-title":"Updated European Association of Urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell renal cell carcinoma","volume":"76","author":"Albiges","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.06.002_bib0265","first-page":"1","article-title":"Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma","volume":"12","author":"Rassy","year":"2018","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.euf.2020.06.002_bib0270","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2217\/imt-2020-0067","article-title":"Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors","volume":"12","author":"Bersanelli","year":"2020","journal-title":"Immunotherapy"},{"key":"10.1016\/j.euf.2020.06.002_bib0275","first-page":"5059","article-title":"Renin angiotensin system deregulation as renal cancer risk factor (Review)","volume":"14","author":"Sobczuk","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.euf.2020.06.002_bib0280","first-page":"389.e1","article-title":"Renin-angiotensin system (RAS) blockade attenuates growth and metastatic potential of renal cell carcinoma in mice","volume":"33","author":"Ara\u00fajo","year":"2015","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"10.1016\/j.euf.2020.06.002_bib0285","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/sj.bjc.6605866","article-title":"Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma","volume":"103","author":"Dolley-Hitze","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euf.2020.06.002_bib0290","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.regpep.2010.07.170","article-title":"Angiotensin-converting enzymes (ACE and ACE2) are downregulated in renal tumors","volume":"165","author":"Larrinaga","year":"2010","journal-title":"Regul Pept"},{"key":"10.1016\/j.euf.2020.06.002_bib0295","first-page":"783","article-title":"Angiotensin-(1-7) inhibits the migration and invasion of A549 human lung adenocarcinoma cells through inactivation of the PI3K\/Akt and MAPK signaling pathways","volume":"27","author":"Ni","year":"2012","journal-title":"Oncol Rep"},{"key":"10.1016\/j.euf.2020.06.002_bib0300","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1158\/1535-7163.MCT-09-0161","article-title":"Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor","volume":"8","author":"Soto-Pantoja","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.euf.2020.06.002_bib0305","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/carcin\/bgh236","article-title":"Inhibition of human lung cancer cell growth by angiotensin-(1-7)","volume":"25","author":"Gallagher","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.euf.2020.06.002_bib0310","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/jcm9030824","article-title":"Endothelin receptor antagonists: status quo and future perspectives for targeted therapy","volume":"9","author":"Enevoldsen","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.euf.2020.06.002_bib0315","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/bs.apha.2016.05.002","article-title":"Endothelin-1: biosynthesis, signaling and vasoreactivity","volume":"77","author":"Houde","year":"2016","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.euf.2020.06.002_bib0320","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.euf.2020.06.002_bib0325","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1039\/C8LC01017J","article-title":"Integrated nanoscale deterministic lateral displacement arrays for separation of extracellular vesicles from clinically-relevant volumes of biological samples","volume":"18","author":"Smith","year":"2018","journal-title":"Lab Chip"},{"key":"10.1016\/j.euf.2020.06.002_bib0330","doi-asserted-by":"crossref","first-page":"18392","DOI":"10.1073\/pnas.1012539107","article-title":"Isolation of circulating tumor cells using a microvortex-generating herringbone-chip","volume":"107","author":"Stott","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.euf.2020.06.002_bib0335","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2019.02.018","article-title":"ExRNA Atlas analysis reveals distinct extracellular RNA cargo types and their carriers present across human biofluids","volume":"177","author":"Murillo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.euf.2020.06.002_bib0340","doi-asserted-by":"crossref","first-page":"12989","DOI":"10.1021\/la300724z","article-title":"Investigating ligand\u2212receptor interactions at bilayer surface using electronic absorption spectroscopy and fluorescence resonance energy transfer","volume":"28","author":"Navneet","year":"2012","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.euf.2020.06.002_bib0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1479-5876-10-55","article-title":"Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma","volume":"10","author":"Redova","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.euf.2020.06.002_bib0350","first-page":"2","article-title":"Real-time liquid biopsies become a reality in cancer treatment","volume":"3","author":"Karachaliou","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.euf.2020.06.002_bib0355","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1039\/c3mb25582d","article-title":"Differential protein profiling of renal cell carcinoma urinary exosomes","volume":"9","author":"Raimondo","year":"2013","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.euf.2020.06.002_bib0360","first-page":"1843","article-title":"Detection of SARS-CoV-2 in different types of clinical specimens","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.euf.2020.06.002_bib0365","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically Ill patients with Middle East respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euf.2020.06.002_bib0370","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euf.2020.06.002_bib0375","doi-asserted-by":"crossref","first-page":"72","DOI":"10.12688\/f1000research.22211.2","article-title":"Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China","volume":"9","author":"Kruse","year":"2020","journal-title":"F1000Research"},{"key":"10.1016\/j.euf.2020.06.002_bib0380","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5483\/BMBRep.2019.52.6.185","article-title":"Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex","volume":"52","author":"Park","year":"2019","journal-title":"BMB Rep"},{"key":"10.1016\/j.euf.2020.06.002_bib0385","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: Initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.euf.2020.06.002_bib0390","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMoa2001191","article-title":"First case of 2019 novel coronavirus in the United States","volume":"382","author":"Holshue","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.euf.2020.06.002_bib0395","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrd.2015.37","article-title":"Coronaviruses\u2014drug discovery and therapeutic options","volume":"15","author":"Zumla","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.euf.2020.06.002_bib0400","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.7150\/ijbs.45498","article-title":"Targeting the endocytic pathway and autophagy process as a novel therapeutic strategy in COVID-19","volume":"16","author":"Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.euf.2020.06.002_bib0405","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1074\/jbc.C300520200","article-title":"A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2","volume":"279","author":"Wong","year":"2004","journal-title":"J Biol Chem"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920301607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920301607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:50:47Z","timestamp":1762498247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456920301607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":81,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2405456920301607"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2020.06.002","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and Kidney Disease: Molecular Determinants and Clinical Implications in Renal Cancer","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2020.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}